All In MedTech

Company

Integra LifeSciences

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

Integra LifeSciences is on our public-company list (ticker IART). Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is free with an account

For Integra LifeSciences we have 4 shareholders with 5% or more and 2 government grants totalling $223K.

Sign up free with your name, company and ZIP code to see the 5%+ shareholders and government grant funders behind device companies.

Latest FDA decisions

The 8 newest of 46 since 2015.

Search the Clearance Tracker

45 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar
  • NCT07805798 · 300 participants (planned) · Start Oct 23, 2026 · Primary completion Aug 31, 2029

    Device: Urinary Bladder Matrix (UBM) Products · For: Tissue Repair; Soft Tissue Reconstruction; Wound Management and 8 more

    Sites: Scottsdale, Arizona; Chapel Hill, North Carolina; Charlotte, North Carolina

69 more trials with a free account

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 23294512
Jan 24583300
Feb 24495200
Mar 24424700
Apr 24494100
May 24515000
Jun 24513400
Jul 24483710
Aug 24605300
Sep 24374520
Oct 24295100
Nov 24553300
Dec 24443200
Jan 25503600
Feb 25503820
Mar 25393400
Apr 25423320
May 25504700
Jun 25305400
Jul 25604300
Aug 25323800
Sep 25502200
Oct 25404100
Nov 25291900
Dec 25332600
Jan 26233000
Feb 26354700
Mar 26393110
Apr 26212500
May 26463400
Jun 26203200
Jul 26272408
Aug 26213206
Sep 26251805
Oct 26311804
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

7 more in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Z-2714-2026 · Started Jun 5, 2026 · Posted by FDA Jul 9, 2026

    Reason given: The current Omni-Tract Surgical Retractor System IFU states a dry time of 30 minutes. Integra LifeSciences has identified that the dry time needs to be extended to 90 minutes, 110 minutes, or 120 minutes depending on the sterilization cycle exposure time used.

    Cause as FDA categorized it: Labeling design · Device type: Retractor (GAD)

369 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.